NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Non Operating Interest Expenses (2015 - 2025)

NextPlat's (NXPL) quarterly Non Operating Interest Expenses came in at $17000.0 in Q4 2025, down 10.53% year-over-year from $19000.0 in Q4 2024, and up 21.43% quarter-over-quarter from $14000.0 in Q3 2025.

Analysis

NextPlat (NXPL) Non Operating Interest Expenses (2015 - 2025) Analysis & Trends

NextPlat (NXPL) has reported Non Operating Interest Expenses for 11 consecutive years, with $17000.0 the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Non Operating Interest Expenses fell 10.53% year-over-year to $17000.0 in Q4 2025; TTM through Dec 2025 was $64000.0, a 20.99% decrease from a year earlier, with the FY2025 full-year figure at $64000.0, down 20.99% from the prior year.
  • Non Operating Interest Expenses was $17000.0 for Q4 2025 at NextPlat, up from $14000.0 in the prior quarter.
  • Over five years, Non Operating Interest Expenses peaked at $940907.0 in Q2 2021 and troughed at $2385.0 in Q3 2021.
  • A 5-year average of $85765.0 and a median of $16000.0 in 2025 frame the typical range for Non Operating Interest Expenses.
  • The widest YoY moves for Non Operating Interest Expenses: up 1345.46% in 2021, down 99.63% in 2021.
  • Over 5 years, Non Operating Interest Expenses stood at $3314.0 in 2021, then surged by 151.99% to $8351.0 in 2022, then jumped by 175.42% to $23000.0 in 2023, then fell by 17.39% to $19000.0 in 2024, then retreated by 10.53% to $17000.0 in 2025.
  • The last three Non Operating Interest Expenses figures came in at $17000.0 (Q4 2025), $14000.0 (Q3 2025), and $15000.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn -
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 120.70 Mn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn -13.26 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn -
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 396.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn -
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn -41.02 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 6.66 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 3,000.00
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 17,000.00
Sep 30, 2025 14,000.00
Jun 30, 2025 15,000.00
Mar 31, 2025 18,000.00
Dec 31, 2024 19,000.00
Sep 30, 2024 22,000.00
Jun 30, 2024 19,000.00
Mar 31, 2024 21,000.00
Dec 31, 2023 23,000.00
Sep 30, 2023 46,000.00
Jun 30, 2023 5,000.00
Mar 31, 2023 5,000.00
Dec 31, 2022 8,351.00
Sep 30, 2022 8,725.00
Jun 30, 2022 3,681.00
Mar 31, 2022 3,243.00
Dec 31, 2021 3,314.00
Sep 30, 2021 2,385.00
Jun 30, 2021 940,907.00
Mar 31, 2021 520,694.00